This tool is donation based and free. 🙏 We're looking for donations to keep it running — $360/year covers our server costs.

$18 of $360 · 5%
Donate
This fact check is over a month old. Newer information may be available — consider rechecking.

Is it true that acetamipride has no proven impact on huma...

“Is it true that acetamipride has no proven impact on human health?”
Not true
Confidence: High Checked on July 29, 2026

Summary

While acetamiprid is generally considered low‑hazard under normal exposure, documented cases of acute poisoning—including severe toxicity and a fatality—demonstrate that it can affect human health. Regulatory assessments also note moderate oral toxicity and classify it as an unlikely human carcinogen, indicating proven health impacts at sufficient doses.

Recheck this fact Runs a fresh check with up-to-date sources

Sources 55 searched

sciencedirect.com
pubmed.ncbi.nlm.nih.gov
www3.epa.gov
  • United States Office of Prevention, Pesticides Environmental Protection

    Acetamiprid pesticide has been classified as a “unlikely” human carcinogen. ... FQPA safety factor =1). The lowest acute aggregate exposure DWLOC is 600 ppb (children 1-6 years) and is greater than ... The lowest short- and intermediate-term DWLOC is 400 ppb for multiple population subgroups.

pmc.ncbi.nlm.nih.gov
  • Statement on the active substance acetamiprid - PMC

    According to the EFSA conclusion, acetamiprid was proposed to be classified as carcinogenic category 2 but not as toxic for reproduction category 2, in accordance with the provisions of Regulation (EC) No 1272/2008. Conditions concerning human health for the consideration of endocrine disrupting ...

  • Acute poisoning with acetamiprid: a case report - PMC

    Checking your browser before accessing pmc.ncbi.nlm.nih.gov · Click here if you are not automatically redirected after 5 seconds

  • Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites - PMC

    Regarding the human studies, one study reported only internal concentrations (no health effects were measured; Table 4 ) and two studies evaluated possible associations between internal exposure data and (health) effects (Table 5 ). These studies were subdivided, because they followed different RoB assessment methods. Heatmap results of the RoB for the endpoints measured in the new in vivo studies notified by PAN Europe in the extension of the mandate for acetamiprid.

downloads.regulations.gov
  • Acetamiprid Human Health Risk Assessment DP Barcode D449925 1 of 46

    Acute lethality studies conducted with acetamiprid indicate it is moderately toxic via the acute · oral route (Category II); however, it has lower toxicity via the acute dermal or inhalation routes · (Categories III). It is non-irritating to the eyes and skin and is not a dermal sensitizer.

This fact check is free and donation-based. $1 powers ~30 fact-checks.

Donate $1 to support fact-checking

Check another fact